Beneficial effect of an antibody against interleukin-2 receptor (daclizumab) in an experimental model of hepatocyte xenotransplantation

Table 1 Survival analysis and survival rate

	Median (95% CI)1	n (%)2
FHF	2 (1-2)	0/13 (0)
XenoTx	6 (3-9)a	4/14 (28.6)e
XenoTx + CsA	11 (8-14)ac	10/14 (71.4)ef
XenoTx + Dmab	15 (14-15)ac	13/14 (92.9)ef
XenoTx + Dmab + CsA	13 (12-15)ac	10/13 (76.9)ef

¹Kaplan Meier-Log-rank test:

^aP < 0.05 vs FHF;

^cP < 0.05 vs XenoTx.

²Chi-square, Fisher’s exact test:

^eP < 0.05 vs FHF;

^fP < 0.05 vs XenoTx. FHF: fulminant hepatic failure.